These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9614382

  • 1. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
    Harn HJ, Shen KL, Liu CA, Ho LI, Yang LS, Yueh KC.
    J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
    [Abstract] [Full Text] [Related]

  • 2. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M, Diaz-Mitoma F, Kumar A.
    Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
    [Abstract] [Full Text] [Related]

  • 3. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E, Runnebaum IB, Möbus VJ, Kieback DG, Kreienberg R.
    Anticancer Res; 1997 Sep; 17(3C):1871-6. PubMed ID: 9216637
    [Abstract] [Full Text] [Related]

  • 4. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A.
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [Abstract] [Full Text] [Related]

  • 5. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA, DeFranzo B, Niloff J, Ottensmeir C.
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [Abstract] [Full Text] [Related]

  • 6. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
    Gao AC, Lou W, Sleeman JP, Isaacs JT.
    Cancer Res; 1998 Jun 01; 58(11):2350-2. PubMed ID: 9622073
    [Abstract] [Full Text] [Related]

  • 7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM.
    Cancer Res; 1998 Aug 15; 58(16):3719-26. PubMed ID: 9721884
    [Abstract] [Full Text] [Related]

  • 8. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani AR.
    Anticancer Res; 1997 Aug 15; 17(6D):4463-6. PubMed ID: 9494551
    [Abstract] [Full Text] [Related]

  • 9. Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells.
    Haegel-Kronenberger H, de la Salle H, Bohbot A, Oberling F, Cazenave JP, Hanau D.
    J Immunol; 1998 Oct 15; 161(8):3902-11. PubMed ID: 9780156
    [Abstract] [Full Text] [Related]

  • 10. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid.
    Fukui M, Whittlesey K, Metcalfe DD, Dastych J.
    Clin Immunol; 2000 Mar 15; 94(3):173-8. PubMed ID: 10692236
    [Abstract] [Full Text] [Related]

  • 11. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY, Poonja LS.
    Indian J Dent Res; 2011 Mar 15; 22(3):493-4. PubMed ID: 22048598
    [Abstract] [Full Text] [Related]

  • 12. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
    Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS, Kreil G, Ponta H, Herrlich P.
    Cancer Res; 1996 Jul 01; 56(13):3134-41. PubMed ID: 8674073
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ, Ho LI, Chang JY, Wu CW, Jiang SY, Lee HS, Lee WH.
    Cancer; 1995 Mar 01; 75(5):1065-71. PubMed ID: 7531611
    [Abstract] [Full Text] [Related]

  • 14. Hyaluronate and its receptors in bone marrow.
    Schade UM, Nehmann N, Horny HP, Prehm P, Delpech B, Krüger WH, Zander AR, Schumacher U.
    Acta Histochem; 2006 Mar 01; 108(2):141-7. PubMed ID: 16713618
    [Abstract] [Full Text] [Related]

  • 15. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A, Takahashi K, Cutler M, Tanabe KK.
    Biochem Biophys Res Commun; 1996 Oct 03; 227(1):110-7. PubMed ID: 8858111
    [Abstract] [Full Text] [Related]

  • 16. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY.
    Cancer Res; 2007 Mar 01; 67(5):2089-97. PubMed ID: 17332338
    [Abstract] [Full Text] [Related]

  • 17. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion.
    Sugimoto K, Tsurumaki Y, Hoshi H, Kadowaki S, LeBousse-Kerdiles MC, Smadja-Joffe F, Mori KJ.
    Exp Hematol; 1994 Jun 01; 22(6):488-94. PubMed ID: 7514542
    [Abstract] [Full Text] [Related]

  • 18. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Li H, Guo L, Li JW, Liu N, Qi R, Liu J.
    Int J Oncol; 2000 Nov 01; 17(5):927-32. PubMed ID: 11029494
    [Abstract] [Full Text] [Related]

  • 19. CD44 in normal human pancreas and pancreatic carcinoma cell lines.
    Ringel J, Jesnowski R, Schmidt C, Ringel J, Köhler HJ, Rychly J, Batra SK, Löhr M.
    Teratog Carcinog Mutagen; 2001 Nov 01; 21(1):97-106. PubMed ID: 11135324
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K, Shimosegawa T, Koizumi M, Toyota T.
    Anticancer Res; 1997 Nov 01; 17(1A):215-9. PubMed ID: 9066654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.